MTat2-Nat

General Information


DRACP ID  DRACP05620

Peptide Name   MTat2-Nat

Sequence  AKKRRQRRRAKKRRQRRR

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  FITC

C-terminal Modification  Natamycin

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C100H196N54O21

Absent amino acids  CDEFGHILMNPSTVWY

Common amino acids  R

Mass  279438

Pl  13.46

Basic residues  14

Acidic residues  0

Hydrophobic residues  2

Net charge  14

Boman Index  -17886

Hydrophobicity  -355.56

Aliphatic Index  11.11

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25467959

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2515

DRACP is developed by Dr.Zheng's team.